文献速递肾癌与肾肿瘤

小肾癌管理方案比较效果的前瞻性队列研究

Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
PubMed 文献 · BJU Int · 2018-08-09

基于DISSRM前瞻性队列638例≤4.0cm小肾癌患者,比较部分肾切除、根治性肾切除、消融和主动监测在生存、肾功能和生活质量方面的效果。7年肿瘤特异生存各组均优良,根治性肾切除肾功能最差,主动监测总生存较差但归因于年龄和合并症。

要点

  • 7年肿瘤特异生存部分肾切除组98.8%,其余各组均为100%
  • 根治性肾切除术后eGFR最低,部分肾切除、消融与主动监测组相当
  • 主动监测组总生存较差,与年龄较大和合并症较多有关

核心结论

  • 各组肿瘤学结局均优良,需干预时保留肾单位的部分肾切除和消融优于根治性肾切除。
  • 主动监测肿瘤学和精神健康结局相当,是特定患者的合理选择。

研究设计与样本

  • 前瞻性维持的DISSRM登记队列研究,纳入638例肿瘤直径≤4.0cm的小肾癌患者。
  • 231例(36.2%)选择部分肾切除,41例(6.4%)根治性肾切除,27例(4.2%)消融,339例(53.1%)主动监测。
  • 采用Kaplan-Meier法和Cox比例风险回归分析生存,混合效应模型分析肾功能和生活质量。

主要发现

  • 7年肿瘤特异生存部分肾切除组为98.8%,根治性肾切除、消融和主动监测组均为100%。
  • 7年总生存部分肾切除组87.9%、根治性肾切除组90.2%、消融组83.5%、主动监测组66.1%。
  • 主动监测组总生存显著差于其他组,可能归因于年龄较大和合并症较多。
  • 根治性肾切除组eGFR最低,其他各组相当。
  • 主动监测组生活质量最低,源于躯体健康评分较低,但各组心理健康评分相似。

临床怎么用

  • 小肾癌需要干预时优先选择部分肾切除或消融等保留肾单位方案,而非根治性肾切除。
  • 对特定患者主动监测是合理选择,肿瘤学与心理健康结局相当。
  • 主动监测患者总生存较差可能与年龄和合并症有关,选择时应综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore the comparative effectiveness of partial nephrectomy (PN), radical nephrectomy (RN), ablative therapies (ablation) and active surveillance (AS) for small renal masses (SRMs; tumour diameter ≤4.0 cm) in the domains of survival, renal function and quality of life (QoL) using the prospectively maintained Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry. PATIENTS AND METHODS: Estimated glomerular filtration rate (eGFR) was calculated from creatinine values to determine renal function. QoL was measured using the Short Form 12 (SF-12) questionnaire. The Kaplan-Meier method and Cox proportional hazards regression were used for survival analysis. The mixed-effects model was used for renal function and QoL analysis. RESULTS: Of 638 patients, 231 (36.2%) chose PN, 41 (6.4%) RN, 27 (4.2%) ablation and 339 (53.1%) AS. Cancer-specific survival at 7 years was 98.8% in PN patients and 100% in all other groups. Overall survival (OS) at 7 years was 87.9%, 90.2%, 83.5% and 66.1% in PN, RN, ablation and AS patients, respectively. The OS rate was significantly worse in the AS group than other groups and likely attributable to older age and increased comorbidities. The eGFR was lowest in RN patients but comparable in all other groups. QoL was lowest in AS patients due to lower physical health scores, but mental health scores were similar in all groups. CONCLUSIONS: With excellent oncological outcomes in all groups, nephron-sparing approaches, like PN and ablation, are preferred over RN when intervention is indicated for SRMs. AS is a reasonable option for select patients, given the comparable oncological and mental health outcomes.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Alam R, Patel HD, Osumah T, et al. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study. BJU Int. 2018. PMID: 30019484. doi:10.1111/bju.14490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。